• FirefoxInstall the new Firefox »
  •  Dow Up 1.49% Nasdaq Up 1.15%

    Novavax, Inc. (NVAX)

    -NasdaqGS
    8.64 Up 0.42(5.11%) Mar 30, 4:00PM EDT
    Add to Portfolio
    Prev Close:8.22
    Open:8.58
    Bid:8.30 x 300
    Ask:8.95 x 500
    1y Target Est:10.38
    Beta:1.12
    Earnings Date:May 5 - May 11 (Est.)
    Day's Range:8.35 - 8.88
    52wk Range:3.34 - 9.95
    Volume:8,085,249
    Avg Vol (3m):5,881,990
    Market Cap:2.06B
    P/E (ttm):N/A
    EPS (ttm):-0.37
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    NVAXUp 5.11%2.06B
    MRKUp 1.02%165.58B
    NVSUp 0.91%243.00B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):64.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.45
    Quarterly EPS Est (Mar-15) :-0.11
    Mean Recommendation*:1.4
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback